Shaping Oncology Policy Through Access and Safety Considerations

Panelists discuss how future oncology policies must integrate both patient access and drug safety to achieve equitable outcomes. They examine the current disconnect between affordability initiatives and clinical evidence, noting that excessive focus on cost can inadvertently compromise safety and efficacy.

Panelists propose that adaptive coverage models incorporating ongoing safety monitoring and outcomes data can help ensure appropriate balance. They stress the importance of policy flexibility that evolves with emerging data and changing standards of care.

The conversation concludes with a call for multistakeholder collaboration—uniting regulators, payers, and clinicians—to ensure policies advance both safety and access objectives.